APA

Cesca M., Morosi L., Berndt A., Fuso Nerini I., Frapolli R., Richter P., Decio A., Dirsch O., Micotti E., Giordano S., D'Incalci M., Davoli E., Zucchetti M. & Giavazzi R. (20161018). Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response. : Molecular cancer therapeutics.

Chicago

Cesca Marta, Morosi Lavinia, Berndt Alexander, Fuso Nerini Ilaria, Frapolli Roberta, Richter Petra, Decio Alessandra, Dirsch Olaf, Micotti Edoardo, Giordano Silvia, D'Incalci Maurizio, Davoli Enrico, Zucchetti Massimo and Giavazzi Raffaella. 20161018. Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response. : Molecular cancer therapeutics.

Harvard

Cesca M., Morosi L., Berndt A., Fuso Nerini I., Frapolli R., Richter P., Decio A., Dirsch O., Micotti E., Giordano S., D'Incalci M., Davoli E., Zucchetti M. and Giavazzi R. (20161018). Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response. : Molecular cancer therapeutics.

MLA

Cesca Marta, Morosi Lavinia, Berndt Alexander, Fuso Nerini Ilaria, Frapolli Roberta, Richter Petra, Decio Alessandra, Dirsch Olaf, Micotti Edoardo, Giordano Silvia, D'Incalci Maurizio, Davoli Enrico, Zucchetti Massimo and Giavazzi Raffaella. Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response. : Molecular cancer therapeutics. 20161018.